Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
Authors: Wang, Yueqin1,2 (AUTHOR), Wei, Jingyao1,2 (AUTHOR), Feng, Luyao1,2 (AUTHOR), Li, Ouwen1,2 (AUTHOR), Huang, Lan3 (AUTHOR), Zhou, Shaoxuan1,2 (AUTHOR), Xu, Yingjie1,2 (AUTHOR), An, Ke1,2 (AUTHOR), Zhang, Yu1,2 (AUTHOR), Chen, Ruiying4 (AUTHOR), He, Lulu5 (AUTHOR), Wang, Qiming6 (AUTHOR), Wang, Han1,2 (AUTHOR), Du, Yue1,2 (AUTHOR), Liu, Ruijuan1,2 (AUTHOR), Huang, Chunmin7 (AUTHOR), Zhang, Xiaojian1,2 (AUTHOR), Yang, Yun-gui7 (AUTHOR) ygyang@big.ac.cn, Kan, Quancheng1,2 (AUTHOR) kanqc@zzu.edu.cn, Tian, Xin1,2 (AUTHOR) tianx@zzu.edu.cn
Source: Molecular Cancer. 5/9/20233, Vol. 22 Issue 1, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-023-01780-4